Alexandros Georgiou
3rd Floor D Block South Wing, St Thomas' Campus
London, ENG SE17EH, United Kingdom
London, ENG SE17EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Improving diabetes management in older adults with cancer: a quality improvement project to enhance monitoring during steroid-based systemic anti-cancer therapy.
Journal: European geriatric medicine
Published: February 25, 2026
Outcomes Following Radiotherapy for Oligoprogressive NSCLC on Immune Checkpoint Inhibitors: A Real-World, Multinational Experience.
Journal: Cancers
Published: November 28, 2025
A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices.
Journal: Current oncology (Toronto, Ont.)
Published: August 04, 2025
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.
Journal: Cancers
Published: July 16, 2025
PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.
Journal: British journal of cancer
Published: August 08, 2024
Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
Journal: Cancers
Published: July 14, 2024
Bedside Flexible Cystoscopy-Guided Ureteric Stent Insertion for Early Control of Sepsis.
Journal: Cureus
Published: April 11, 2023
Operative outcomes for wide awake local anesthesia versus regional and general anesthesia for flexor tendon repair.
Journal: Hand surgery & rehabilitation
Published: August 18, 2021
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer.
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAFV600 wild-type colorectal cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 27, 2021
Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAFV600 -Wild-Type Colorectal Cancer.
Journal: Molecular cancer research : MCR
Published: December 13, 2019
Last Updated: 09/26/2026